Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance-Reference-Cited by-同舟云学术

Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance

Published:2017-11-17 Issue:1 Volume:67 Page:145-158
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Gaggini Melania¹,Carli Fabrizia¹,Rosso Chiara²,Buzzigoli Emma¹,Marietti Milena²,Della Latta Veronica¹,Ciociaro Demetrio¹,Abate Maria Lorena²,Gambino Roberto²,Cassader Maurizio²,Bugianesi Elisabetta²,Gastaldelli Amalia¹^ORCID

Affiliation:

1. Cardiometabolic Risk Unit, Institute of Clinical Physiology; National Research Council; Pisa Italy

2. Division of Gastroenterology and Hepatology and Laboratory of Diabetology, Department of Medical Sciences; University of Turin; Turin Italy

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29465/fullpdf

Reference47 articles.

1. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease;European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO);J Hepatol,2016

2. Metabolomics applied to diabetes research: moving from information to knowledge;Bain;Diabetes,2009

3. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance;Ferrannini;Diabetes,2013

4. Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver;Lehmann;Diabetes Care,2013

5. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver;Kotronen;Diabetes,2009

Cited by 326 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in Obese Chinese;Computational and Structural Biotechnology Journal;2024-12

2. Altered biliary microbial and metabolic profile reveals the crosstalk between NAFLD and cholelithiasis;Clinics and Research in Hepatology and Gastroenterology;2024-10

3. Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-10-01

4. Hepatic estrogen receptor alpha drives masculinization in post-menopausal women with metabolic dysfunction-associated steatotic liver disease;JHEP Reports;2024-10

5. Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease;Livers;2024-09-12